ClinicalTrials.Veeva

Menu

Using the Visualization for Lifestyle Change in Patients At Risk of Cardiovascular Diseases

U

University Maribor

Status

Completed

Conditions

CGM
Coronary Artery Disease
Lifestyle
Coronary Heart Disease
Continuous Glucose Monitoring
Visual Analytics
Cardiovascular Diseases
Behaviour Change
Heart Diseases

Treatments

Diagnostic Test: Visualization
Device: CGM

Study type

Interventional

Funder types

Other

Identifiers

NCT06226948
05a/2I-2023

Details and patient eligibility

About

In the framework of PhD research, the investigators will present a visualization of estimation of CVDs risk and the possibility of monitoring blood glucose levels in real-time. Based on the results, the investigators will assess the association of these with lifestyle change. The findings highlight the need for sufficiently reliable and high-quality evaluations of visualizations, technologies or applications used in the family medicine.

Full description

The investigators reviewed the existing literature and found little research on the use of Continuous Glucose Monitoring (CGM) and visualization of SCORE2 prognostic model in healthy populations and how they can influence lifestyle change. The investigators will conduct a randomised control trial with 3 intervention groups and 1 control gropu. The investigators also found that primary care nurses are still using paper-based methods to calculate CVDs by using colour-coded charts. Therefore, the investigators will use the visual tool of the SCORE2 scale to identify possible increased participants motivation using visualization. The investigators will also confirm or refute lifestyle change by calculating biological age.

Enrollment

120 patients

Sex

All

Ages

40+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • individuals ages more than 40 years
  • without serious disease progression
  • at least one risk factor for CVDs

Exclusion criteria

  • individuals younger than 40 years
  • with serious disease progression
  • without risk factor for CVDs

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

120 participants in 4 patient groups

Intervention group 1
Experimental group
Description:
Participants will use a continuous blood glucose monitoring and visualization of CVDs risk.
Treatment:
Device: CGM
Diagnostic Test: Visualization
Intervention group 2
Experimental group
Description:
Participants will use a continuous blood glucose monitoring.
Treatment:
Device: CGM
Intervention group 3
Experimental group
Description:
Participants will use a visualization of CVDs risk.
Treatment:
Diagnostic Test: Visualization
Control group
No Intervention group
Description:
No intervention.

Trial contacts and locations

1

Loading...

Central trial contact

Adrijana Svenšek, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems